adenosine diphosphate has been researched along with Bleeding in 150 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 58 (38.67) | 18.7374 |
| 1990's | 15 (10.00) | 18.2507 |
| 2000's | 20 (13.33) | 29.6817 |
| 2010's | 42 (28.00) | 24.3611 |
| 2020's | 15 (10.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dizdarevic, AM; Eyileten, C; Gasecka, A; Jarosz-Popek, J; Lang, IM; Nowak, A; Postula, M; Siller-Matula, JM; Ufnal, M; Wolska, M | 1 |
| Fareed, MS; He, Y; Lu, Y; Su, J; Wang, K; Wang, P; Wang, Z; Yan, W; Yang, C; Zhang, H; Zhou, J | 1 |
| Costa, TGR; Franken, M; Guerra, JCC; Katz, M; Lemos Neto, PA; Pesaro, AEP | 1 |
| Hanumegowda, S; Kengaiah, J; Laxmaiah, RK; Manjappa, B; Martin, SS; Nandish, SKM; Ramachandraiah, C; Sannaningaiah, D; Shinde, M; Shivaiah, A; Srinivasa, C | 1 |
| Dangelmaier, C; Kostyak, JC; Kunapuli, SP; Mauri, B; Patel, A | 1 |
| Hagisawa, K; Ishida, O; Kearney, BM; Kinoshita, M; Nakashima, H; Takeoka, S; Tsutsumi, K; Yamanaka, N | 1 |
| Artoni, A; Bernardi, F; Castaman, G; Cattaneo, M; Gachet, C; Lecchi, A; Lunghi, B; Margaglione, M; Paniccia, R; Santacroce, R; Scavone, M | 1 |
| Bryant, SC; Jaffe, AS; Karon, BS; Katzman, BM; Scott, RJ; Wockenfus, AM | 1 |
| Du, W; Freyer, A; Hobson, S; Jahr, JS; Mack, R; McCallum, S; Minger, K; Searle, S | 1 |
| Barbian, M; Deschmann, E; Feldman, HA; Norman, M; Saxonhouse, MA; Sola-Visner, M | 1 |
| Guo, L; Huang, Q; Shi, X; Wang, G; Yang, Y; Yuan, D; Yuan, Y; Zhang, H; Zhao, Y | 1 |
| Ferraris, VA | 1 |
| Brewster, LM | 1 |
| Collet, JP; Thiele, H | 1 |
| Braun, D; Brunner, S; Deseive, S; Hagl, C; Hausleiter, J; Istrefi, M; Kellnar, A; Kika, S; Kleeberger, J; Krieg, K; Kupka, D; Lüsebrink, E; Massberg, S; Orban, M; Petzold, T; Scherer, C; Sibbing, D; Stark, K; Stocker, TJ; Würbel, S | 1 |
| Guo, Y; He, D; Luo, X; Qu, W; Wu, L; Yu, Z; Zhang, Y; Zhao, J | 1 |
| Almquist, J; Gennemark, P; Goodman, J; Janefeldt, A; Johansson, KJ; Maqbool, S; Nylander, S; Pehrsson, S; Sanchez, J; Sandinge, AS | 1 |
| Asrud, KS; Bakke, M; Berven, FS; Bjørnstad, R; Døskeland, SO; Herfindal, L; Hoivik, EA; Kopperud, RK; Lunde, THF; Myhren, L; Nygaard, G; Oveland, E; Selheim, F | 1 |
| Chen, X; Cheng, F; Cheng, X; Feng, C; Hu, S; Li, Y; Yan, D; Zeenat, S; Zhou, Z | 1 |
| Berger, JS | 1 |
| Baquet, M; Bauer, A; Gross, L; Hagl, C; Holdt, L; Jochheim, D; Massberg, S; Mehilli, J; Nitschke, T; Orban, M; Sibbing, D; Teupser, D; Zadrozny, M | 1 |
| Bhagirath, VC; Chan, NC; Dale, B; de Vries, TAC; Eikelboom, JW; Ginsberg, JS; Hirsh, J; Kruger, PC; Xu, K | 1 |
| Hagisawa, K; Kinoshita, M; Saitoh, D; Sakai, H; Seki, S; Takeoka, S; Takikawa, M | 1 |
| Altamirano, AV; Callender, RA; Cattano, D; Mukalel, J; Pivalizza, EG | 1 |
| Okamura, Y; Takeoka, S | 1 |
| Alexopoulos, D; Angiolillo, DJ; Aradi, D; Becker, RC; Bhatt, DL; Bonello, L; Curzen, N; Geisler, T; Gurbel, PA; Jeong, YH; Kirtane, A; Mahla, E; Marcucci, R; Price, MJ; Rao, SV; Reny, JL; Sibbing, D; Siller-Matula, J; Stone, GW; Tantry, US; Ten Berg, J; Trenk, D; Waksman, R | 1 |
| Espinosa, EV; Karim, ZA; Khasawneh, FT; Lin, OA; Vemana, HP | 1 |
| Gross, PL; Kim, PY; Ni, R; Vaezzadeh, N; Weitz, JI | 1 |
| Alessi, MC; Cambien, F; Canault, M; Chelghoum, N; Germain, M; Ghalloussi, D; Grosdidier, C; Guinier, M; Kuijpers, TW; Morange, PE; Nurden, AT; Peiretti, F; Perret, C; Pierres, A; Pillois, X; Raslova, H; Saut, N; Tregouet, DA; van den Berg, TK | 1 |
| Boldron, C; Bonnet-Lignon, S; Bono, F; Delesque-Touchard, N; Herbert, JM; Lassalle, G; Millet, L; Pflieger, AM; Salel, V; Savi, P | 1 |
| Abendschein, D; Broekman, MJ; Chen, R; Drosopoulos, JH; Jeong, SS; Marcus, AJ; Moeckel, D; Nguyen, A; Robson, SC; Sun, X | 1 |
| Burbury, K; Cole-Sinclair, M; Filshie, R; Horton, L; Kamel, S; Keating, MJ; Khot, A; Levade, M; Nandurkar, H; Reynolds, J; Sandhu, S; Schischka, S; Tam, CS; Tan, S; Ysebaert, L | 1 |
| Doi, M; Hagisawa, K; Handa, M; Iwaya, K; Kinoshita, M; Nishida, Y; Nishikawa, K; Saitoh, D; Seki, S; Suzuki, H; Takeoka, S; Yanagawa, R | 1 |
| Boateng, KB; Brewster, LM; Clark, JF; Horjus, DL; Nieuwland, R; Schaap, MC; Sturk, A; van Montfrans, GA | 1 |
| Cam, B; Sagdilek, E; Savci, V; Yildirim, N | 1 |
| Ashcroft, GP; Ford, I; Hetherington, JJ; Jansen, JO | 1 |
| Cattaneo, M | 3 |
| Jakubowski, JA; Mizuno, M; Ohno, K; Sugidachi, A; Tomizawa, A | 1 |
| Baker-Groberg, SM; Haley, KM; Lattimore, S; McCarty, OJ; Recht, M | 1 |
| Dong, T; Jin, L; Liao, H; Yan, H; Yu, H; Zhang, B; Zou, X | 1 |
| Anstrom, KJ; Baker, BA; Cohen, DJ; Effron, MB; Henry, TD; McCoy, LA; Messenger, JC; Peterson, ED; Wang, TY; Zettler, ME | 1 |
| Bergmeier, W; Conley, PB; Lee, RH; Piatt, R | 1 |
| Horovitz, Y; Lahav, J; Nakav, S; Rabizadeh, E; Steinberg Shemer, O; Tamary, H; Tanous, O; Yacobovich, J; Yaniv, I; Zoldan, M | 1 |
| Frederiksen, H; Hvas, AM; Nielsen, C; Sprogøe, U; Vinholt, PJ | 1 |
| Brandt, JT; Farid, NA; Jakubowski, JA; Li, YG; Payne, CD; Salazar, DE; Small, DS; Winters, KJ | 1 |
| Becker, RC; Conley, PB; French, PA; Gachet, C; Goodman, SG; Kuliopulos, A; Moliterno, DJ; Roe, MT; Smyth, SS; Steinhubl, SR; Weitz, JI; Woulfe, DS | 1 |
| Bai, L; Fang, W; Huo, J; Kong, Y; Xiong, J; Yunman, L | 1 |
| Crain, EJ; Hua, J; Rehfuss, R; Schumacher, WA; Watson, CA; Wong, PC | 1 |
| Eto, K; Fujie, T; Handa, M; Ikeda, Y; Maekawa, I; Maruyama, H; Okamura, Y; Takeoka, S | 1 |
| Daly, ME; Dawood, BB; Goodeve, AC; Lester, WA; Makris, M; Mumford, AD; Mundell, SJ; Peake, IR; Rodeghiero, F; Watson, SP; Wilde, JT | 1 |
| Goodall, AH; Hayes, PD; Jones, CI; McMahon, GS; Naylor, AR; Webster, SE | 1 |
| Cheng, H; Dai, K; Fan, Y; Li, S; Shi, Q; Wang, Y; Wang, Z; Yan, R; Yuan, Y; Zhuang, F | 1 |
| Alessi, MC; Bali, L; Bonnet, JL; Cayla, G; Cuisset, T; Frere, C; Gaborit, B; Morange, PE; Poyet, R; Quilici, J | 1 |
| Braun, S; Kastrati, A; Mehilli, J; Morath, T; Schömig, A; Schulz, S; Sibbing, D; Stegherr, J; von Beckerath, N | 1 |
| Bolliger, D; Levy, JH; Rumph, B; Szlam, F; Tanaka, KA | 1 |
| Fukushima, K; Iwata, Y; Kitahara, H; Kobayashi, Y; Komuro, I; Kuroda, N; Nomura, F; Ooyama, M | 1 |
| Cai, YL; Ruan, JL; Wang, JP; Wu, YX; Xiong, CM; Xu, HX; Ye, YJ | 1 |
| Filipiak, KJ; Grabowski, M; Huczek, Z; Kochman, J; Michalak, M; Opolski, G; Roik, M | 1 |
| de la Peña, A; Espinoza, J; Perusquía, M | 1 |
| Alessi, MC; Bonnet, JL; Cuisset, T; Fourcade, L; Gaborit, B; Grosdidier, C; Molines, L; Morange, PE; Pankert, M; Quilici, J | 1 |
| Castilloux, JF; Hayward, CP; Liu, Y; Moffat, KA; Pai, M; Seecharan, J | 1 |
| Costa, MM; Da Silva, AS; França, RT; Jaques, JA; Leal, DB; Lopes, ST; Mazzanti, CM; Monteiro, SG; Paim, CB; Paim, FC; Pimentel, VC; Schetinger, MR; Souza, VC | 1 |
| Ding, Z; Du, H; Liu, G; Pan, C; Wei, X; Ye, J; Zhang, S; Zhang, Y | 1 |
| Doi, M; Hagisawa, K; Handa, M; Iwaya, K; Katsuno, S; Kinoshita, M; Nishikawa, K; Saitoh, D; Sakamoto, T; Seki, S; Shono, S; Suzuki, H; Takeoka, S; Yanagawa, R | 1 |
| Bal Dit Sollier, C; Caplain, H; Drouet, L | 1 |
| Galán, JA; Pérez, JC; Russell, DH; Russell, WK; Sánchez, EE; Soto, JG | 1 |
| Aguejouf, O; Belon, P; Doutremepuich, C; Eizayaga, FX | 1 |
| Fitzgerald, DJ; Maree, AO | 1 |
| Dawood, BB; Watson, SP; Wilde, J | 1 |
| Bucciarelli, P; Cattaneo, M; Lecchi, A; Lussana, F; Podda, GM | 1 |
| Ebell, W; Grossmann, R; Hanenberg, H; Holzhauer, S; Schindler, D; Sitaru, AG; Walter, U; Wirbelauer, J | 1 |
| D'Angelo, A; Galli, G; Mannucci, PM; Pareti, FI; Sautebin, L; Smith, JB | 1 |
| Chen, YC; Ku, CS; Wu, KK | 1 |
| Born, GV; Shafi, S; Thorngren, M | 1 |
| Boiarinov, GA; Khvorov, NV; Shvets, NA; Snopova, LB | 1 |
| Casonato, A; Fabris, F; Girolami, A; Randi, M; Sbrojavacca, R | 1 |
| Ambrus, JL; Kulaylat, M; Stadler, S | 1 |
| Kamiguti, AS; Laing, GD; Lowe, GM; Theakston, RD; Warrell, DA; Zuzel, M | 1 |
| Mandelbaum, FR; Matos, MF; Sampaio, CA; Serrano, SM | 1 |
| Anderson, JG; Bennett, JS; Callan, MB; Giger, U; Haskins, ME; Hayden, JE; Phillips, DK | 1 |
| Deniz, A; Hart, S; Kietzmann, M; Nolte, I; Sommer, B | 1 |
| Frojmovic, MM; Searcy, GP; Wong, T | 1 |
| Cheryk, LA; Gentry, PA; Healey, R; Shanks, RD | 1 |
| Bentley, R; Bostwick, JS; Dunwiddie, CT; Kasiewski, CJ; Leadley, RJ; McVey, MJ; Perrone, MH; White, FJ | 1 |
| Bernat, A; Herbert, JM; Hoffmann, P; Lalé, A; Savi, P | 1 |
| Balduini, CL; Belletti, S; Gamba, G; Noris, P; Spedini, P | 1 |
| Fitzgerald, DJ; Quinn, MJ | 1 |
| Droulle, C; Elaerts, J; Hézard, N; Metz, D; Nazeyrollas, P; Nguyen, P; Potron, G | 1 |
| Conley, PB; England, L; Hollopeter, G; Jantzen, HM; Julius, D; Li, G; Nurden, A; Nurden, P; Ramakrishnan, V; Vincent, D; Yang, RB | 1 |
| de Miranda, AL; Fuly, AL; Guimarães, JA; Zingali, RB | 1 |
| Collinson, LM; Copeland, NG; Gautam, R; Jenkins, NA; McGarry, MP; Novak, EK; Reddington, M; Swank, RT | 1 |
| Buyniski, JP; Fleming, JS | 1 |
| Chiu, RC; Modry, DL | 1 |
| Carvalho, AC; Coggins, C; Steiner, RW | 1 |
| Ehinger, B; Pandolfi, M | 1 |
| Kozhura, VL | 1 |
| Beurling-Harbury, C; Galvan, CA | 1 |
| Eldor, A | 1 |
| Arkel, YS | 1 |
| Bachmann, F; Gilson, JR; McKenna, R; Weinberg, M; Whittaker, B | 1 |
| Goodner, CJ; Harker, LA; Koerker, DJ | 1 |
| Cattaneo, M; Lecchi, A; Mannucci, PM; McGregor, JL; Randi, AM | 1 |
| Bellucci, S; Bouillot, C; Cox, A; Hardisty, R; Heilmann, E; Hourdillé, P; Legrand, C; Nokes, T; Pannocchia, A; Pidard, D | 1 |
| Crane, S; Johnstone, IB; Viel, L; Whiting, T | 1 |
| Abrams, CS; Budzynski, AZ; Ellison, N; Shattil, SJ | 1 |
| Collen, D; Coller, BS; Finkelstein, D; Gimple, LW; Gold, HK; Johns, JA; Leinbach, RC; Werner, W; Yasuda, T; Ziskind, AA | 1 |
| Jackson, ML; Meric, SM; Rousseaux, CG; Willis, SE | 1 |
| Bennett, D; Cummins, D; Farrar, B; Fisher-Hoch, SP; Machin, SJ; Mackie, IJ; McCormick, JB; Perez, G; Walshe, KJ | 1 |
| Forsythe, LT; Jackson, ML; Meric, SM | 1 |
| Born, GV; Cusack, NJ; Kakkar, A; McClure, MO | 1 |
| Endo, Y; Hamanaka, S; Iwamoto, K; Mamiya, S; Miura, AB; Niitsu, H | 1 |
| Boneu, B; Fernandez, F | 1 |
| Dyerberg, J; Knudsen, F | 1 |
| Born, GV | 1 |
| Aggeler, PM; O'Reilly, RA; Sahud, MA | 1 |
| Booyse, F; Kisieleski, D; Rafelson, M; Seeler, R | 1 |
| Corby, DG; Greene, HL; Putnam, CW | 1 |
| Baluda, VP; Nestaĭko, GV | 1 |
| Douglas, AS; Ogston, D | 1 |
| Alfrey, CP; Bradshaw, W; Brown, CH; Natelson, EA; Williams, TW | 1 |
| Caspar, C; Galbrun, M; Marcel, GA; Sabatier, C | 1 |
| Ciliberto, R; Ricca, M | 1 |
| Hardisty, RM; Howard, MA; Hutton, RA | 1 |
| Hussey, CV; Sanfelippo, MJ | 1 |
| Green, D; Rossi, EC | 1 |
| McBride, JA; Wallett, LH | 1 |
| Rabiner, SF | 1 |
| Stevens, DJ | 1 |
| Higashi, O; Kikuchi, Y; Konno, K | 1 |
| Manmi, S; Matsuda, T; Murakami, M; Odake, K; Takase, M | 1 |
| Sahud, MA | 1 |
| Beutler, E | 1 |
| Aledort, LM; Berger, S; Gilbert, HS; Hanson, JP; Wasserman, LR | 1 |
| Ekert, H; Sheers, M | 1 |
| Baue, AE; Chaudry, IH; Sayeed, MM; Wurth, MA | 1 |
| Arapakis, G; Gardikas, C; Papayannis, AG; Stathakis, NE | 1 |
| Baluda, VP; Sushkevich, GN | 1 |
| Caen, JP; Cronberg, S | 1 |
| Marcus, AJ | 1 |
| Crosby, WH; Durocher, JR; Mielke, CH; Zucker, S | 1 |
| Mielke, CH; Zucker, S | 1 |
| Phillips, GB; Safrit, HF; Weiss, HJ | 1 |
| Fortier, NL; Herman, CM; Rodkey, FL; Valeri, CR | 1 |
| Bergentz, SE; Leandoer, L; Ljungqvist, U | 1 |
| Caen, J | 1 |
| Arfors, KE; Dhall, DP; Matheson, NA; McKenzie, FN | 1 |
| Arfors, KE; Bygdeman, S; Dhall, DP; Matheson, NA; McKenzie, FN | 1 |
| Inceman, S; Tangün, Y | 1 |
17 review(s) available for adenosine diphosphate and Bleeding
| Article | Year |
|---|---|
Oral Antiplatelet Therapy for Secondary Prevention of Acute Coronary Syndrome.
Topics: Acute Coronary Syndrome; Adenosine Diphosphate; Administration, Oral; Aging; Blood Platelets; Cyclooxygenase 1; Diabetes Mellitus; Drug Administration Schedule; Hemorrhage; Humans; Platelet Aggregation Inhibitors; Practice Guidelines as Topic; Purinergic P2Y Receptor Antagonists; Receptor, PAR-1; Receptors, Purinergic P2Y12; Renal Insufficiency; Risk Factors; Secondary Prevention; Thrombin; Thromboxane A2; Time Factors; Vascular Diseases | 2018 |
[Development of nanoparticle for coagulant].
Topics: Adenosine Diphosphate; Animals; Coagulants; Drug Design; Hemorrhage; Humans; Molecular Targeted Therapy; Nanoparticles | 2013 |
P2Y12 receptors: structure and function.
Topics: Adenosine Diphosphate; Animals; Blood Platelets; Cardiovascular Diseases; Fibrinolytic Agents; Hemorrhage; Humans; Platelet Aggregation Inhibitors; Protein Conformation; Purinergic P2Y Receptor Antagonists; Receptors, Purinergic P2Y12; Signal Transduction; Structure-Activity Relationship | 2015 |
G-protein-coupled receptors as signaling targets for antiplatelet therapy.
Topics: Adenosine Diphosphate; Animals; Blood Platelets; Drug Design; Hemorrhage; Humans; Platelet Aggregation Inhibitors; Purinergic P2 Receptor Antagonists; Receptor, PAR-1; Receptors, G-Protein-Coupled; Receptors, Purinergic P2Y1; Receptors, Purinergic P2Y12; Receptors, Thrombin; Receptors, Thromboxane; Signal Transduction; Thrombin; Thromboxanes | 2009 |
The platelet P2Y₁₂ receptor for adenosine diphosphate: congenital and drug-induced defects.
Topics: Adenosine; Adenosine Diphosphate; Animals; Blood Platelet Disorders; Blood Platelets; Clopidogrel; Female; Hemorrhage; Humans; Male; Mice; Mutation; Piperazines; Platelet Aggregation; Platelet Aggregation Inhibitors; Prasugrel Hydrochloride; Purinergic P2Y Receptor Antagonists; Receptors, Purinergic P2Y12; Signal Transduction; Thiophenes; Ticagrelor; Ticlopidine | 2011 |
Bleeding manifestations of congenital and drug-induced defects of the platelet P2Y12 receptor for adenosine diphosphate.
Topics: Adenosine; Adenosine Diphosphate; Adenosine Monophosphate; Animals; Clinical Trials, Phase III as Topic; Clopidogrel; Hemorrhage; Humans; Piperazines; Platelet Activation; Prasugrel Hydrochloride; Quinazolinones; Receptors, Purinergic P2Y12; Sulfonamides; Thiophenes; Ticagrelor; Ticlopidine | 2011 |
Variable platelet response to aspirin and clopidogrel in atherothrombotic disease.
Topics: Adenosine Diphosphate; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Atherosclerosis; Biomarkers; Biotransformation; Blood Coagulation Tests; Blood Platelets; Cardiovascular Diseases; Clopidogrel; Cyclooxygenase 1; Cyclooxygenase Inhibitors; Drug Interactions; Drug Resistance; Hemorrhage; Humans; Platelet Activation; Platelet Aggregation Inhibitors; Platelet Function Tests; Prospective Studies; Randomized Controlled Trials as Topic; Receptors, Purinergic P2; Receptors, Purinergic P2Y1; Receptors, Purinergic P2Y12; Thrombosis; Thromboxane A2; Thromboxane B2; Ticlopidine; Treatment Failure | 2007 |
Ticlopidine and clopidogrel.
Topics: Adenosine Diphosphate; Adenylyl Cyclase Inhibitors; Adenylyl Cyclases; Angina, Unstable; Aspirin; Bone Marrow Diseases; Carbamazepine; Cardiovascular Diseases; Clopidogrel; Combined Modality Therapy; Coronary Disease; Drug Interactions; Hemorrhage; Humans; Myocardial Infarction; Peripheral Vascular Diseases; Phenytoin; Platelet Aggregation Inhibitors; Randomized Controlled Trials as Topic; Receptors, Purinergic P2; Safety; Stents; Theophylline; Thrombolytic Therapy; Ticlopidine | 1999 |
Evaluation of platelet aggregation in disorders of hemostasis.
Topics: Adenosine Diphosphate; Adenosine Triphosphate; Anemia, Megaloblastic; Anti-Inflammatory Agents; Blood Coagulation Disorders; Blood Coagulation Tests; Blood Platelet Disorders; Blood Platelets; Carbenicillin; Collagen; Epinephrine; Hemorrhage; Humans; Isoantibodies; Leukemia; Myeloproliferative Disorders; Platelet Aggregation; Postoperative Complications; Purpura, Thrombocytopenic; Ristocetin; Stress, Psychological; Uremia; von Willebrand Diseases | 1976 |
The role of the hematocrit in bleeding.
Topics: Adenosine Diphosphate; Bleeding Time; Erythrocytes; Hematocrit; Hemorrhage; Humans; Platelet Activation | 1987 |
Adenosine diphosphate as a mediator of platelet aggregation in vivo.
Topics: Adenosine Diphosphate; Adenosine Triphosphate; Animals; Arterioles; Arteriosclerosis; Blood Platelets; Creatine Kinase; Hemorrhage; Hemostasis; Humans; Phosphocreatine; Platelet Adhesiveness; Platelet Aggregation; Thrombosis; Venules | 1985 |
[Ultrastructure of the thrombocytes as an index of their functional state].
Topics: Acute Disease; Adenosine Diphosphate; Adenosine Triphosphatases; Agglutination; Animals; Blood Platelets; Blood Proteins; Cell Membrane; Cell Membrane Permeability; Cytoplasmic Granules; Energy Metabolism; Hemorrhage; Histocytochemistry; Humans; Microscopy, Electron; Mitochondria; Organoids; Phagocytosis; Pinocytosis; Radiation Injuries, Experimental; Receptors, Drug; Serotonin | 1972 |
Disorders of platelet function.
Topics: Adenosine Diphosphate; Adolescent; Aspirin; Blood Coagulation Disorders; Blood Coagulation Factors; Blood Coagulation Tests; Blood Platelet Disorders; Blood Platelets; Clot Retraction; Collagen; Female; Hemorrhage; Humans; Male; Middle Aged; Platelet Adhesiveness; Thrombocythemia, Essential; Tourniquets; Wiskott-Aldrich Syndrome | 1972 |
The clinical relevance of platelet function tests.
Topics: Adenosine Diphosphate; Aspirin; Blood Cell Count; Blood Coagulation Factors; Blood Coagulation Tests; Blood Platelet Disorders; Blood Platelets; Hemorrhage; Humans; Phospholipids; Platelet Adhesiveness; Purpura, Thrombocytopenic; Thrombocytopenia; von Willebrand Diseases | 1972 |
Uremic bleeding.
Topics: Adenosine Diphosphate; Blood Coagulation Disorders; Blood Coagulation Factors; Blood Coagulation Tests; Blood Platelet Disorders; Blood Urea Nitrogen; Guanidines; Hemorrhage; Humans; Kidney Failure, Chronic; Phenols; Phospholipids; Renal Dialysis; Succinates; Urea; Uremia | 1972 |
Vascular hemostasis: a review.
Topics: Adenosine Diphosphate; Blood Coagulation; Blood Coagulation Disorders; Blood Coagulation Tests; Blood Platelet Disorders; Blood Vessels; Carbon Dioxide; Chemoreceptor Cells; Collagen; Ehlers-Danlos Syndrome; Hemorrhage; Hemostasis; Humans; Marfan Syndrome; Oxygen; Platelet Adhesiveness; Pressoreceptors; Purpura, Thrombocytopenic; Serotonin; Thrombocytopenia; Thrombocytosis; Vasomotor System; von Willebrand Diseases | 1973 |
[The role of thrombocytes in hemostasis and maintenance of vascular wall resistance under normal and pathologic conditions].
Topics: Adenosine Diphosphate; Adenosine Triphosphate; Animals; Blood Coagulation; Blood Platelets; Blood Transfusion; Clot Retraction; Collagen; Epinephrine; Hemorrhage; Humans; Microscopy, Electron; Platelet Adhesiveness; Radiation Injuries, Experimental; Serotonin; Thrombin; Thrombocytopenia | 1971 |
7 trial(s) available for adenosine diphosphate and Bleeding
| Article | Year |
|---|---|
In Vitro Reversal of the Anti-Aggregant Effect of Ticagrelor Using Untreated Platelets.
Topics: Acute Coronary Syndrome; Adenosine Diphosphate; Adult; Blood Platelets; Cells, Cultured; Female; Healthy Volunteers; Hemorrhage; Humans; Male; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Transfusion; Platelet-Rich Plasma; Risk; Thrombosis; Ticagrelor; Young Adult | 2018 |
Human CalDAG-GEFI gene (RASGRP2) mutation affects platelet function and causes severe bleeding.
Topics: Adenosine Diphosphate; Blood Coagulation Disorders, Inherited; Blood Platelets; Cell Line; Female; Guanine Nucleotide Exchange Factors; Guanosine Triphosphate; Hemorrhage; Heterozygote; Homozygote; Humans; Male; Megakaryocytes; Membrane Proteins; Mutation; Neoplasm Proteins; Platelet Aggregation; Platelet Glycoprotein GPIIb-IIIa Complex; Protein Kinase C; Shelterin Complex; Telomere-Binding Proteins | 2014 |
The Prognostic Value of ADP-Induced Platelet Aggregation for Bleeding Complications in Low - Intermediate Risk Patients with Acute Coronary Syndrome Taking Clopidogrel After Percutaneous Coronary Intervention.
Topics: Acute Coronary Syndrome; Adenosine Diphosphate; Aged; Clopidogrel; Female; Follow-Up Studies; Hemorrhage; Humans; Male; Middle Aged; Percutaneous Coronary Intervention; Platelet Aggregation; Prognosis; Risk Factors; Ticlopidine | 2017 |
Switching directly to prasugrel from clopidogrel results in greater inhibition of platelet aggregation in aspirin-treated subjects.
Topics: Adenosine Diphosphate; Adult; Aspirin; Clopidogrel; Drug-Related Side Effects and Adverse Reactions; Female; Hemorrhage; Humans; Male; Middle Aged; Piperazines; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Function Tests; Prasugrel Hydrochloride; Thiophenes; Ticlopidine | 2008 |
Low molecular weight heparin significantly reduces embolisation after carotid endarterectomy--a randomised controlled trial.
Topics: Adenosine Diphosphate; Aged; Anticoagulants; Arachidonic Acid; Aspirin; Carotid Artery Diseases; Dalteparin; Double-Blind Method; Drug Therapy, Combination; Endarterectomy, Carotid; Female; Hemorrhage; Heparin; Humans; Infusions, Intravenous; Intracranial Embolism; Male; Middle Aged; Odds Ratio; Platelet Aggregation; Platelet Aggregation Inhibitors; Risk Assessment; Stroke; Time Factors; Treatment Outcome; Ultrasonography, Doppler, Transcranial | 2009 |
No alteration in platelet function or coagulation induced by EGb761 in a controlled study.
Topics: Adenosine Diphosphate; Adult; Blood Coagulation; Blood Platelets; Dose-Response Relationship, Drug; Double-Blind Method; Fibrinolysis; Ginkgo biloba; Hemorrhage; Humans; Male; Middle Aged; Plant Extracts; Platelet Aggregation; Prospective Studies; Thrombin; Tissue Plasminogen Activator | 2003 |
Reference curves for aggregation and ATP secretion to aid diagnose of platelet-based bleeding disorders: effect of inhibition of ADP and thromboxane A(2) pathways.
Topics: Adenosine Diphosphate; Adenosine Monophosphate; Adenosine Triphosphate; Blood Platelets; Cyclooxygenase Inhibitors; Diagnosis, Differential; Female; Hemorrhage; Humans; Indomethacin; Male; Platelet Aggregation; Platelet Function Tests; Purinergic P2 Receptor Agonists; Purinergic P2 Receptor Antagonists; Receptors, Purinergic P2; Receptors, Purinergic P2Y1; Receptors, Purinergic P2Y12; Reference Standards; Secretory Vesicles; Thromboxane A2 | 2007 |
126 other study(ies) available for adenosine diphosphate and Bleeding
| Article | Year |
|---|---|
High concentration of symmetric dimethylarginine is associated with low platelet reactivity and increased bleeding risk in patients with acute coronary syndrome.
Topics: Acute Coronary Syndrome; Adenosine Diphosphate; Arginine; Biomarkers; Female; Hemorrhage; Humans; Male; Percutaneous Coronary Intervention; Platelet Aggregation Inhibitors | 2022 |
An Injectable Peptide Hydrogel Constructed of Natural Antimicrobial Peptide J-1 and ADP Shows Anti-Infection, Hemostasis, and Antiadhesion Efficacy.
Topics: Adenosine Diphosphate; Animals; Anti-Infective Agents; Antimicrobial Peptides; Hemorrhage; Hemostasis; Hemostatics; Hydrogels; Mice; Peptides; Rats; Tissue Adhesions | 2022 |
Low platelet reactivity in patients with myocardial infarction treated with aspirin plus ticagrelor.
Topics: Adenosine Diphosphate; Aspirin; Hemorrhage; Humans; Myocardial Infarction; Platelet Aggregation Inhibitors; Ticagrelor; Treatment Outcome | 2022 |
Sorghum Protein Extract Protects RBC from Sodium Nitrite-Induced Oxidative Stress and Exhibits Anticoagulant and Antiplatelet Activity.
Topics: Adenosine Diphosphate; Animals; Anticoagulants; Antioxidants; Blood Coagulation; Epinephrine; Hemorrhage; Mice; Oxidative Stress; Platelet Aggregation Inhibitors; Protein Carbonylation; Sodium Nitrite; Sorghum; Superoxide Dismutase; Thrombosis | 2021 |
D121 Located within the DRY Motif of P2Y12 Is Essential for P2Y12-Mediated Platelet Function.
Topics: Adenosine Diphosphate; Animals; Aspartic Acid; Blood Platelets; Hemorrhage; Humans; Mice; Platelet Aggregation; Platelet Function Tests; Purinergic P2Y Receptor Antagonists; Receptors, Purinergic P2Y12 | 2022 |
In vitro study on the effect of fibrinogen γ-chain peptide-coated ADP-encapsulated liposomes on postcardiopulmonary bypass coagulopathy using patient blood.
Topics: Adenosine Diphosphate; Animals; Blood Coagulation Disorders; Blood Platelets; Cardiopulmonary Bypass; Fibrinogen; Hemorrhage; Humans; Liposomes; Peptides; Platelet Aggregation; Rabbits | 2023 |
Severe bleeding and absent ADP-induced platelet aggregation associated with inherited combined CalDAG-GEFI and P2Y
Topics: Adenosine Diphosphate; Blood Platelets; Hemorrhage; Humans; Platelet Activation; Platelet Aggregation; Platelet Aggregation Inhibitors; Receptors, Purinergic P2Y12 | 2020 |
Estimating short- and long-term reference change values and index of individuality for tests of platelet function.
Topics: Adenosine Diphosphate; Arachidonic Acid; Aspirin; Biological Variation, Population; Female; Follow-Up Studies; Hemorrhage; Humans; Male; Normal Distribution; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Function Tests; Reference Values; Thrombosis | 2019 |
Platelet Function: Meloxicam Intravenous in Whole Blood Samples From Healthy Volunteers.
Topics: Adenosine Diphosphate; Administration, Intravenous; Adult; Anti-Inflammatory Agents, Non-Steroidal; Blood Specimen Collection; Collagen; Cyclooxygenase Inhibitors; Drug Compounding; Epinephrine; Female; Healthy Volunteers; Hemorrhage; Humans; Ketorolac; Male; Meloxicam; Nanoparticles; Pain; Platelet Aggregation; Platelet Function Tests; Reagent Kits, Diagnostic | 2020 |
Association of Bleeding Scores and Platelet Transfusions With Platelet Counts and Closure Times in Response to Adenosine Diphosphate (CT-ADPs) Among Preterm Neonates With Thrombocytopenia.
Topics: Adenosine Diphosphate; Cohort Studies; Hemorrhage; Humans; Infant, Newborn; Infant, Premature; Platelet Function Tests; Platelet Transfusion; Thrombocytopenia | 2020 |
Lower Platelet Aggregation Is a Risk Factor for Dual Antiplatelet Therapy-Associated Bleeding: A Preliminary Retrospective Study with Genotype Analysis.
Topics: Acute Coronary Syndrome; Adenosine Diphosphate; Aged; Arachidonic Acid; Aspirin; Case-Control Studies; Dual Anti-Platelet Therapy; Female; Genotype; Glutathione S-Transferase pi; Hemorrhage; Humans; Male; Middle Aged; Percutaneous Coronary Intervention; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIb-IX Complex; Polymorphism, Single Nucleotide; Receptors, Cell Surface; Retrospective Studies; Ticagrelor | 2020 |
Adenosine Diphosphate Receptor Inhibitors: Balancing Perioperative Bleeding and Protection From Adverse Coronary Events.
Topics: Adenosine Diphosphate; Clopidogrel; Hemorrhage; Humans; Purinergic P2Y Receptor Antagonists; Ticlopidine | 2021 |
Because of its association with major bleeding the ADP-binding enzyme creatine kinase should be estimated in studies of patients treated for non-ST-segment elevation acute coronary syndromes (NSTE-ACS).
Topics: Acute Coronary Syndrome; Adenosine Diphosphate; Creatine Kinase; Hemorrhage; Humans; Platelet Aggregation Inhibitors | 2021 |
Major bleeding and the ADP-binding enzyme creatine kinase in non-ST-segment elevation acute coronary syndromes.
Topics: Acute Coronary Syndrome; Adenosine Diphosphate; Creatine Kinase; Creatine Kinase, MB Form; Hemorrhage; Humans | 2021 |
ADP-induced platelet reactivity and bleeding events in patients with acute myocardial infarction complicated by cardiogenic shock.
Topics: Acute Disease; Adenosine Diphosphate; Aged; Blood Platelets; Female; Hemorrhage; Humans; Male; Myocardial Infarction; Shock, Cardiogenic | 2022 |
Thromboelastography predicts dual antiplatelet therapy-related hemorrhage in patients with acute ischemic stroke.
Topics: Adenosine Diphosphate; Drug Therapy, Combination; Hemorrhage; Humans; Ischemic Stroke; Platelet Aggregation Inhibitors; Stroke; Thrombelastography; Treatment Outcome | 2022 |
Hemostatic effects of the ticagrelor antidote MEDI2452 in pigs treated with ticagrelor on a background of aspirin.
Topics: Adenosine; Adenosine Diphosphate; Animals; Antibodies, Neutralizing; Antidotes; Aspirin; Biotinylation; Blood Pressure; Broadly Neutralizing Antibodies; Hemorrhage; Hemostasis; Humans; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Function Tests; Swine; Ticagrelor; Time Factors | 2017 |
Epac1-deficient mice have bleeding phenotype and thrombocytes with decreased GPIbβ expression.
Topics: Adenosine Diphosphate; Animals; Blood Coagulation Factors; Blood Platelets; Cell Size; Collagen; Exocytosis; Fetus; Guanine Nucleotide Exchange Factors; Hemorrhage; Liver; Megakaryocytes; Mice, Inbred C57BL; P-Selectin; Phenotype; Platelet Glycoprotein GPIb-IX Complex; Thrombin | 2017 |
Different chemical groups modification on the surface of chitosan nonwoven dressing and the hemostatic properties.
Topics: Adenosine Diphosphate; Ammonium Compounds; Animals; Bandages; Blood Coagulation; Chitosan; Hemorrhage; Hemostatics; Humans; Platelet Adhesiveness; Platelet Aggregation; Rabbits; Siloxanes; Surface Properties | 2018 |
Platelet Reactivity and Early Outcomes after Transfemoral Aortic Valve Implantation.
Topics: Adenosine Diphosphate; Aged; Aged, 80 and over; Aortic Valve; Blood Platelets; Cells, Cultured; Cohort Studies; Female; Femoral Artery; Follow-Up Studies; Germany; Hemorrhage; Humans; Male; Platelet Activation; Platelet Aggregation Inhibitors; Postoperative Complications; Predictive Value of Tests; Prognosis; Risk Factors; Transcatheter Aortic Valve Replacement; Treatment Outcome | 2018 |
Combination therapy using fibrinogen γ-chain peptide-coated, ADP-encapsulated liposomes and hemoglobin vesicles for trauma-induced massive hemorrhage in thrombocytopenic rabbits.
Topics: Adenosine Diphosphate; Animals; Blood Substitutes; Disease Models, Animal; Drug Therapy, Combination; Fibrinogen; Hemoglobins; Hemorrhage; Liposomes; Oligopeptides; Rabbits; Wounds and Injuries | 2019 |
Hidden implications: potential antiplatelet effects of adjuvant anaesthetic agents.
Topics: Adenosine Diphosphate; Adjuvants, Anesthesia; Aged; Aspirin; Cholecystectomy, Laparoscopic; Clopidogrel; Female; Hemorrhage; Humans; Intraoperative Complications; Platelet Aggregation; Platelet Aggregation Inhibitors; Thrombelastography; Ticlopidine | 2013 |
Consensus and update on the definition of on-treatment platelet reactivity to adenosine diphosphate associated with ischemia and bleeding.
Topics: Acute Coronary Syndrome; Adenosine Diphosphate; Angioplasty, Balloon, Coronary; Blood Platelets; Coronary Artery Disease; Coronary Thrombosis; Hemorrhage; Humans; Myocardial Ischemia; Platelet Aggregation Inhibitors; Platelet Function Tests; Purinergic P2Y Receptor Antagonists; Receptors, Purinergic P2Y12; Risk Assessment; Risk Factors; Stents | 2013 |
The antidepressant 5-HT2A receptor antagonists pizotifen and cyproheptadine inhibit serotonin-enhanced platelet function.
Topics: Adenosine Diphosphate; Animals; Antidepressive Agents; Blotting, Western; Calcium; Carotid Artery Thrombosis; Clopidogrel; Cyproheptadine; Flow Cytometry; Hemorrhage; Humans; Immunoprecipitation; Indoles; Male; Mice; Mice, Inbred C57BL; Piperazines; Pizotyline; Platelet Activation; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Function Tests; Receptor, Serotonin, 5-HT2A; Serotonin; Serotonin Antagonists; Serotonin Receptor Agonists; Ticlopidine | 2014 |
Comparison of the effect of coagulation and platelet function impairments on various mouse bleeding models.
Topics: Adenosine Diphosphate; Animals; Antibodies; Anticoagulants; Arteries; Blood Coagulation; Blood Coagulation Tests; Blood Platelets; Disease Models, Animal; Dose-Response Relationship, Drug; Hemorrhage; Heparin; Male; Mice, Inbred C57BL; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Function Tests; Platelet Glycoprotein GPIIb-IIIa Complex; Saphenous Vein; Tail | 2014 |
SAR216471, an alternative to the use of currently available P2Y₁₂ receptor inhibitors?
Topics: Adenosine Diphosphate; Administration, Oral; Animals; Binding, Competitive; Biological Availability; Blood Platelets; CHO Cells; Cricetulus; Disease Models, Animal; Dose-Response Relationship, Drug; Fibrinolytic Agents; Hemorrhage; Humans; Indoles; Male; Platelet Aggregation; Platelet Aggregation Inhibitors; Protein Binding; Purinergic P2Y Receptor Antagonists; Pyridazines; Rats, Sprague-Dawley; Receptors, Purinergic P2; Receptors, Purinergic P2Y12; Signal Transduction; Thionucleotides; Thrombosis; Transfection | 2014 |
Optimizing human apyrase to treat arterial thrombosis and limit reperfusion injury without increasing bleeding risk.
Topics: Adenosine Diphosphate; Animals; Apyrase; Clopidogrel; Coronary Circulation; Dogs; Fibrinolysis; Hemorrhage; Humans; Mice, Inbred C57BL; Myocardial Infarction; Myocardial Reperfusion Injury; Piperazines; Platelet Aggregation; Prasugrel Hydrochloride; Risk Factors; Thiophenes; Thrombosis; Ticlopidine; Time Factors; Tissue Plasminogen Activator; Treatment Outcome; Vascular Patency | 2014 |
Ibrutinib inhibits collagen-mediated but not ADP-mediated platelet aggregation.
Topics: Adenine; Adenosine Diphosphate; Aged; Aged, 80 and over; Antineoplastic Agents; Blood Platelets; Cells, Cultured; Collagen; Female; Hemorrhage; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Lymphoma, Mantle-Cell; Male; Middle Aged; Piperidines; Platelet Aggregation; Pyrazoles; Pyrimidines; Severity of Illness Index | 2015 |
Treatment with fibrinogen γ-chain peptide-coated, adenosine 5'-diphosphate-encapsulated liposomes as an infusible hemostatic agent against active liver bleeding in rabbits with acute thrombocytopenia.
Topics: Acute Disease; Adenosine Diphosphate; Animals; Blood Coagulation; Fibrinogen; Hemorrhage; Liposomes; Liver; Male; Platelet Aggregation Inhibitors; Rabbits; Thrombocytopenia | 2015 |
Creatine kinase inhibits ADP-induced platelet aggregation.
Topics: Adenosine Diphosphate; Adult; Blood Platelets; Creatine Kinase; Hemorrhage; Humans; Male; Platelet Aggregation; Receptors, Purinergic P2; Receptors, Purinergic P2Y12 | 2014 |
Cytidine 5'-diphosphocholine differentially affects hemostatic parameters in diverse conditions in rats: an investigation via thromboelastography.
Topics: Adenosine Diphosphate; Animals; Blood Coagulation; Collagen; Cytidine Diphosphate Choline; Hemoglobins; Hemorrhage; Hemostasis; Hemostatics; Lactic Acid; Male; Partial Thromboplastin Time; Platelet Aggregation; Prothrombin Time; Rats; Rats, Wistar; Thrombelastography; Time Factors | 2015 |
Intraoperative changes in platelet function in relation to moderate haemorrhage.
Topics: Adenosine Diphosphate; Aged; Anticoagulants; Arachidonic Acid; Arthroplasty, Replacement, Hip; Blood Coagulation Tests; Blood Platelets; Collagen; Female; Hemorrhage; Humans; Intraoperative Period; Male; Middle Aged; Peptide Fragments; Platelet Activation; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Function Tests; Prospective Studies | 2015 |
Prasugrel reduces ischaemic infarct volume and ameliorates neurological deficits in a non-human primate model of middle cerebral artery thrombosis.
Topics: Adenosine Diphosphate; Administration, Oral; Animals; Blood Pressure; Disease Models, Animal; Dose-Response Relationship, Drug; Haplorhini; Hemorrhage; Infarction, Middle Cerebral Artery; Macaca fascicularis; Male; Myocardial Ischemia; Platelet Aggregation; Platelet Aggregation Inhibitors; Prasugrel Hydrochloride; Purinergic P2Y Receptor Antagonists; Receptors, Purinergic P2Y12; Stroke; Thrombosis; Time Factors | 2015 |
Assessment of neonatal platelet adhesion, activation, and aggregation.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Adenosine Diphosphate; Adult; Blood Platelets; C-Reactive Protein; Cell Separation; Flow Cytometry; Glycoproteins; Hemorrhage; Humans; Immunoreceptor Tyrosine-Based Activation Motif; Infant, Newborn; Lectins, C-Type; Oligopeptides; Platelet Activation; Platelet Adhesiveness; Platelet Aggregation; Platelet Function Tests; Platelet Glycoprotein GPIb-IX Complex; Platelet Glycoprotein GPIIb-IIIa Complex; Receptors, G-Protein-Coupled; Signal Transduction | 2016 |
Switching of adenosine diphosphate receptor inhibitor after hospital discharge among myocardial infarction patients: Insights from the Treatment with Adenosine Diphosphate Receptor Inhibitors: Longitudinal Assessment of Treatment Patterns and Events after
Topics: Adenosine; Adenosine Diphosphate; Aged; Cardiovascular Diseases; Clopidogrel; Drug Substitution; Female; Hemorrhage; Humans; Longitudinal Studies; Male; Middle Aged; Myocardial Infarction; Patient Discharge; Patient Preference; Platelet Aggregation Inhibitors; Prasugrel Hydrochloride; Purinergic P1 Receptor Antagonists; Ticagrelor; Ticlopidine | 2017 |
Effects of ibrutinib treatment on murine platelet function during inflammation and in primary hemostasis.
Topics: Adenine; Adenosine Diphosphate; Animals; Blood Platelets; Collagen; Crotalid Venoms; Gene Expression Regulation; Hemorrhage; Hemostasis; Inflammation; Lectins, C-Type; Lipopolysaccharides; Lung; Membrane Glycoproteins; Mice; Oligopeptides; Piperidines; Platelet Aggregation; Platelet Membrane Glycoproteins; Protein Kinase Inhibitors; Pyrazoles; Pyrimidines; Receptors, Purinergic P2Y12; Skin | 2017 |
Evaluating platelet function disorders in children with bleeding tendency - A single center study.
Topics: Adenosine Diphosphate; Adolescent; Arachidonic Acid; Automation, Laboratory; Blood Platelets; Child; Child, Preschool; Epinephrine; Female; Hemorrhage; Humans; Infant; Infant, Newborn; Male; Platelet Aggregation; Platelet Function Tests; Retrospective Studies; Severity of Illness Index | 2017 |
Measurement of platelet aggregation, independently of patient platelet count: a flow-cytometric approach.
Topics: Adenosine Diphosphate; Adolescent; Adult; Aged; Carrier Proteins; Female; Flow Cytometry; Hemorrhage; Humans; Leukemia, Myeloid, Acute; Male; Middle Aged; Myelodysplastic Syndromes; P-Selectin; Peptides; Platelet Aggregation; Platelet Count; Platelet Function Tests; Reference Values; Reproducibility of Results; Risk; Thrombocytopenia; Young Adult | 2017 |
Anticoagulant and antithrombotic activity of a new peptide pENW (pGlu-Asn-Trp).
Topics: Adenosine Diphosphate; Animals; Anticoagulants; Dose-Response Relationship, Drug; Endothelium, Vascular; Enzyme-Linked Immunosorbent Assay; Fibrinolysis; Fibrinolytic Agents; Hemorrhage; Injections, Intravenous; Mice; Mice, Inbred ICR; Microscopy, Electron, Transmission; Molecular Structure; Molecular Weight; Oligopeptides; Platelet Aggregation; Pyrrolidonecarboxylic Acid; Rabbits; Rats; Rats, Sprague-Dawley; Thrombosis; Whole Blood Coagulation Time | 2009 |
Clopidogrel versus prasugrel in rabbits. Effects on thrombosis, haemostasis, platelet function and response variability.
Topics: Adenosine Diphosphate; Administration, Oral; Animals; Binding, Competitive; Bleeding Time; Clopidogrel; Disease Models, Animal; Dose-Response Relationship, Drug; Fibrinolytic Agents; Hemorrhage; Hemostasis; Male; Piperazines; Platelet Aggregation; Platelet Aggregation Inhibitors; Prasugrel Hydrochloride; Purinergic P2 Receptor Antagonists; Rabbits; Receptors, Purinergic P2; Receptors, Purinergic P2Y12; Thionucleotides; Thiophenes; Thrombosis; Ticlopidine | 2009 |
Development of fibrinogen gamma-chain peptide-coated, adenosine diphosphate-encapsulated liposomes as a synthetic platelet substitute.
Topics: Adenosine Diphosphate; Animals; Blood Coagulation; Blood Platelets; Capsules; Coated Materials, Biocompatible; Drug Delivery Systems; Fibrinogen; Hemorrhage; Hemostasis; Liposomes; Nanoparticles; Rabbits; Rats; Thrombocytopenia | 2009 |
Identification and characterization of a novel P2Y 12 variant in a patient diagnosed with type 1 von Willebrand disease in the European MCMDM-1VWD study.
Topics: Adenosine Diphosphate; Animals; CHO Cells; Cricetinae; Cricetulus; Europe; Hemorrhage; Humans; Mutation; Platelet Activation; Protein Binding; Purinergic P2 Receptor Agonists; Receptors, Purinergic P2; Receptors, Purinergic P2Y12; Societies, Medical; von Willebrand Diseases | 2009 |
Effects of microgravity and hypergravity on platelet functions.
Topics: Adenosine Diphosphate; Animals; Blood Platelets; Collagen; Cytoskeleton; Hemorrhage; Hemostasis; Hindlimb Suspension; Humans; Hypergravity; Membrane Glycoproteins; Membrane Proteins; Mice; Models, Animal; P-Selectin; Platelet Adhesiveness; Platelet Aggregation; Platelet Glycoprotein GPIb-IX Complex; Ristocetin; Space Flight; Thrombosis; Time Factors; von Willebrand Factor; Weightlessness Simulation | 2009 |
Predictive value of post-treatment platelet reactivity for occurrence of post-discharge bleeding after non-ST elevation acute coronary syndrome. Shifting from antiplatelet resistance to bleeding risk assessment?
Topics: Acute Coronary Syndrome; Adenosine Diphosphate; Aged; Arachidonic Acid; Aspirin; Biomarkers; Cell Adhesion Molecules; Clopidogrel; Coronary Artery Bypass; Drug Therapy, Combination; Female; Gastrointestinal Hemorrhage; Hemorrhage; Humans; Intracranial Hemorrhages; Male; Microfilament Proteins; Middle Aged; Patient Discharge; Phosphoproteins; Phosphorylation; Pilot Projects; Platelet Activation; Platelet Aggregation Inhibitors; Platelet Function Tests; Predictive Value of Tests; Prospective Studies; Risk Assessment; Ticlopidine; Time Factors; Treatment Outcome | 2009 |
Antiplatelet effects of clopidogrel and bleeding in patients undergoing coronary stent placement.
Topics: Adenosine Diphosphate; Aged; Angioplasty, Balloon, Coronary; Chi-Square Distribution; Clopidogrel; Coronary Artery Disease; Drug-Eluting Stents; Female; Germany; Hemorrhage; Humans; Logistic Models; Male; Middle Aged; Odds Ratio; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Function Tests; Predictive Value of Tests; Risk Assessment; Risk Factors; ROC Curve; Severity of Illness Index; Thrombosis; Ticlopidine; Time Factors; Treatment Outcome | 2010 |
In vitro effects of recombinant activated factor VIIa (NovoSeven) on clopidogrel-induced platelet inhibition.
Topics: Adenosine Diphosphate; Aged; Aged, 80 and over; Angioplasty, Balloon, Coronary; Clopidogrel; Coagulants; Collagen; Coronary Artery Disease; Factor VIIa; Female; Hemorrhage; Humans; Male; Middle Aged; Platelet Aggregation; Platelet Aggregation Inhibitors; Recombinant Proteins; Thrombin; Ticlopidine; Time Factors; Treatment Outcome | 2010 |
Effect of 450-mg loading dose of clopidogrel on platelet function in Japanese patients undergoing coronary stent placement.
Topics: Adenosine Diphosphate; Aged; Angioplasty, Balloon, Coronary; Asian People; Clopidogrel; Coronary Artery Disease; Female; Hemorrhage; Humans; Japan; Male; Middle Aged; Platelet Aggregation; Platelet Aggregation Inhibitors; Stents; Ticlopidine; Time Factors; Treatment Outcome | 2010 |
Ent-16β,17-dihydroxy-kauran-19-oic acid, a kaurane diterpene acid from Siegesbeckia pubescens, presents antiplatelet and antithrombotic effects in rats.
Topics: 6-Ketoprostaglandin F1 alpha; Adenosine Diphosphate; Animals; Asteraceae; Coronary Thrombosis; Cyclic AMP; Diterpenes, Kaurane; Epoprostenol; Female; Fibrinolytic Agents; Hemorrhage; In Vitro Techniques; Male; Mice; Mice, Inbred ICR; Platelet Aggregation; Platelet Aggregation Inhibitors; Rats; Rats, Wistar; Thrombin; Thromboxane A2; Thyroglobulin | 2011 |
Medium on-treatment platelet reactivity to ADP is favorable in patients with acute coronary syndromes undergoing coronary stenting.
Topics: Acute Coronary Syndrome; Adenosine Diphosphate; Aged; Aged, 80 and over; Angioplasty, Balloon, Coronary; Female; Hemorrhage; Humans; Ischemia; Kaplan-Meier Estimate; Male; Middle Aged; Platelet Activation; Platelet Aggregation Inhibitors; Prognosis; Stents | 2011 |
Mifepristone (RU 486) induces vasodilation and inhibits platelet aggregation: nongenomic and genomic action to cause hemorrhage.
Topics: Adenosine Diphosphate; Animals; Aorta, Thoracic; Endothelium, Vascular; Female; Gene Expression Regulation; Hemorrhage; Humans; In Vitro Techniques; Male; Mifepristone; Platelet Aggregation; Potassium Chloride; Pregnancy; Rats; Rats, Wistar; Serotonin; Umbilical Arteries; Vasodilation | 2011 |
Comparison of platelet reactivity and clopidogrel response in patients ≤ 75 Years Versus > 75 years undergoing percutaneous coronary intervention for non-ST-segment elevation acute coronary syndrome.
Topics: Acute Coronary Syndrome; Adenosine Diphosphate; Age Factors; Aged; Aged, 80 and over; Angioplasty, Balloon, Coronary; Aspirin; Clopidogrel; Drug Resistance; Follow-Up Studies; Hemorrhage; Humans; Middle Aged; Myocardial Ischemia; Platelet Aggregation; Platelet Aggregation Inhibitors; Prospective Studies; Recurrence; Stents; Ticlopidine | 2011 |
A prospective cohort study of light transmission platelet aggregometry for bleeding disorders: is testing native platelet-rich plasma non-inferior to testing platelet count adjusted samples?
Topics: Adenosine Diphosphate; Adult; Blood Coagulation Disorders; Blood Platelets; Cells, Cultured; Cohort Studies; Collagen; Epinephrine; Feasibility Studies; Female; Hemorrhage; Humans; Light; Male; Middle Aged; Platelet Aggregation; Platelet Count; Platelet Function Tests; Platelet-Rich Plasma; Prospective Studies | 2011 |
Activities of ectonucleotidases and adenosine deaminase in platelets of dogs experimentally infected with Rangelia vitalii.
Topics: Adenosine; Adenosine Deaminase; Adenosine Diphosphate; Adenosine Monophosphate; Adenosine Triphosphate; Animals; Babesia; Babesiosis; Blood Coagulation Disorders; Blood Platelets; Brazil; Deamination; Dog Diseases; Dogs; Female; Hemorrhage; Hydrolysis; Nucleotidases; Platelet Count | 2012 |
BF066, a novel dual target antiplatelet agent without significant bleeding.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Adenine; Adenosine; Adenosine Diphosphate; Adenosine Triphosphate; Animals; Arachidonic Acid; Arterioles; Chlorides; Collagen; Ferric Compounds; Fibrinogen; Hemorrhage; Humans; Immobilized Proteins; Mice; Mice, Inbred C57BL; Oligopeptides; Phosphodiesterase Inhibitors; Phosphoric Diester Hydrolases; Platelet Aggregation; Platelet Aggregation Inhibitors; Receptor, Adenosine A2A; Thrombin; Thrombosis | 2012 |
Fibrinogen γ-chain peptide-coated, ADP-encapsulated liposomes rescue thrombocytopenic rabbits from non-compressible liver hemorrhage.
Topics: Acute Disease; Adenosine Diphosphate; Animals; Blood Coagulation Tests; Blood Platelets; Disease Models, Animal; Feasibility Studies; Fibrinogen; Hemorrhage; Hemostasis; Hemostatics; Liposomes; Liver Diseases; Male; Microscopy, Immunoelectron; Oligopeptides; Platelet Aggregation; Platelet Count; Rabbits; Thrombocytopenia; Time Factors; Wounds, Penetrating | 2012 |
Isolation and characterization of two disintegrins inhibiting ADP-induced human platelet aggregation from the venom of Crotalus scutulatus scutulatus (Mohave Rattlesnake).
Topics: Adenosine Diphosphate; Animals; Chromatography, Gel; Chromatography, Ion Exchange; Chromatography, Liquid; Crotalid Venoms; Disintegrins; Fibrinolysis; Gelatinases; Hemorrhage; Humans; In Vitro Techniques; Mass Spectrometry; Platelet Aggregation; Platelet Aggregation Inhibitors; Viperidae | 2006 |
Platelet aggregation in portal hypertension and its modification by ultra-low doses of aspirin.
Topics: Adenosine Diphosphate; Animals; Aspirin; Fibrinogen; Hemorrhage; Humans; Hypertension, Portal; Injections, Subcutaneous; Male; Partial Thromboplastin Time; Platelet Aggregation; Platelet Aggregation Inhibitors; Prothrombin Time; Rats; Rats, Wistar | 2005 |
Usefulness of PFA-100 testing in the diagnostic screening of patients with suspected abnormalities of hemostasis: comparison with the bleeding time.
Topics: Adenosine Diphosphate; Adolescent; Adult; Aged; Aged, 80 and over; Bleeding Time; Blood Coagulation Disorders; Blood Coagulation Tests; Case-Control Studies; Child; Child, Preschool; Collagen; Epinephrine; Equipment Design; Female; Hemorrhage; Hemostasis; Humans; Male; Middle Aged; Predictive Value of Tests; Reproducibility of Results; Risk Assessment; Sensitivity and Specificity; Severity of Illness Index; Surveys and Questionnaires; von Willebrand Diseases | 2007 |
Decreased platelet reactivity identified by whole blood flow cytometry in Fanconi anaemia patients.
Topics: Adenosine Diphosphate; Adolescent; Blood Platelets; Case-Control Studies; Child; Child, Preschool; Cross-Sectional Studies; Fanconi Anemia; Female; Flow Cytometry; Hemorrhage; Humans; Male; P-Selectin; Peptide Fragments; Platelet Activation; Platelet Count; Platelet Function Tests; Platelet Membrane Glycoproteins; Receptors, Thrombin; Thrombocytopenia | 2007 |
Congenital deficiency of thromboxane and prostacyclin.
Topics: Adenosine Diphosphate; Adult; Arachidonic Acids; Aspirin; Blood Coagulation Tests; Blood Platelet Disorders; Cells, Cultured; Chromatography, Thin Layer; Epoprostenol; Hemorrhage; Humans; Male; Oxygenases; Plasma; Platelet Aggregation; Prostaglandins; Thromboxane A2; Thromboxanes | 1980 |
Reduced platelet sialyltransferase activity in patients with primary release disorder.
Topics: Adenine Nucleotides; Adenosine Diphosphate; Adult; Aged; Blood Platelet Disorders; Blood Platelets; Female; Hemorrhage; Humans; Platelet Function Tests; Sialyltransferases; Transferases | 1980 |
Thromboxane A2 in skin-bleeding-time blood and in clotted venous blood before and after administration of acetylsalicylic acid.
Topics: Adenosine Diphosphate; Adult; Aspirin; Bleeding Time; England; Hemorrhage; Hemostasis; Humans; Male; Platelet Aggregation; Platelet Function Tests; Skin; Sweden; Thromboxane A2; Thromboxane B2; Thromboxanes | 1983 |
[Effect of sodium oxybutyrate on macroergic phosphates, function and ultrastructure of the myocardium in blood loss].
Topics: Adenosine Diphosphate; Adenosine Monophosphate; Adenosine Triphosphate; Animals; Creatine; Dogs; Energy Metabolism; Heart; Hemodynamics; Hemorrhage; Hydroxybutyrates; Hypotension; Myocardium; Phosphocreatine; Sodium Oxybate | 1984 |
The possible value of platelet aggregation studies in patients with increased platelet number.
Topics: Adenosine Diphosphate; Adult; Aged; Collagen; Epinephrine; Female; Hemorrhage; Humans; Male; Middle Aged; Platelet Aggregation; Thrombocytosis | 1981 |
Hemorrheologic effects of metabolites of pentoxifylline (Trental).
Topics: Adenosine Diphosphate; Epinephrine; Erythrocyte Deformability; Erythrocyte Membrane; Erythrocytes; Hemorrhage; Humans; Membrane Fluidity; Pentoxifylline; Platelet Aggregation | 1995 |
Biological properties of the venom of the Papuan black snake (Pseudechis papuanus): presence of a phospholipase A2 platelet inhibitor.
Topics: Adenosine Diphosphate; Animals; Anticoagulants; Blood Platelets; Collagen; Dose-Response Relationship, Drug; Electrophoresis, Polyacrylamide Gel; Epinephrine; Factor X; Hemorrhage; Homeostasis; Humans; Injections, Intravenous; Injections, Subcutaneous; Male; Mice; Phospholipases A; Phospholipases A2; Platelet Aggregation Inhibitors; Platelet Factor 3; Rats; Rats, Sprague-Dawley; Ristocetin; Snake Venoms; Thrombin | 1994 |
Basic proteinases from Bothrops moojeni (caissaca) venom--I. Isolation and activity of two serine proteinases, MSP 1 and MSP 2, on synthetic substrates and on platelet aggregation.
Topics: Adenosine Diphosphate; Amides; Amino Acid Sequence; Animals; Blood Coagulation; Caseins; Crotalid Venoms; Guinea Pigs; Hemorrhage; Horses; Humans; In Vitro Techniques; Kinins; Molecular Sequence Data; Molecular Weight; Platelet Aggregation; Serine Endopeptidases; Serine Proteinase Inhibitors; Tosylarginine Methyl Ester | 1993 |
Inherited platelet delta-storage pool disease in dogs causing severe bleeding: an animal model for a specific ADP deficiency.
Topics: Adenine Nucleotides; Adenosine Diphosphate; Animals; Blood Platelets; Dogs; Hemorrhage; Hemostasis; Male; Microscopy, Electron; Platelet Aggregation; Platelet Storage Pool Deficiency | 1995 |
[Effect of acetylsalicylic acid on platelet aggregation and capillary bleeding in healthy cats].
Topics: Adenosine Diphosphate; Animals; Aspirin; Capillaries; Cats; Collagen; Dose-Response Relationship, Drug; Hemorrhage; In Vitro Techniques; Platelet Aggregation; Platelet Aggregation Inhibitors; Reference Values; Thrombin | 1995 |
Platelets from bleeding Simmental cattle have a long delay in both ADP-activated expression of GpIIB-IIIA receptors and fibrinogen-dependent platelet aggregation.
Topics: Adenosine Diphosphate; Animals; Blood Platelet Disorders; Cattle; Cattle Diseases; Fibrinogen; Hemorrhage; Platelet Aggregation; Platelet Glycoprotein GPIIb-IIIa Complex | 1996 |
An inherited platelet function defect in a Simmental crossbred herd.
Topics: Adenosine Diphosphate; Animals; Blood Coagulation; Blood Coagulation Disorders; Blood Platelets; Cattle; Cattle Diseases; Factor XI; Female; Hemorrhage; Heterozygote; Male; Platelet Activating Factor; Platelet Aggregation; Platelet Function Tests | 1997 |
Comparison of enoxaparin, hirulog, and heparin as adjunctive antithrombotic therapy during thrombolysis with rtPA in the stenosed canine coronary artery.
Topics: Adenosine Diphosphate; Animals; Aspirin; Bleeding Time; Collagen; Coronary Thrombosis; Dogs; Drug Evaluation, Preclinical; Drug Synergism; Drug Therapy, Combination; Enoxaparin; Factor Xa Inhibitors; Female; Fibrinolytic Agents; Hemorrhage; Hemostasis; Heparin; Hirudin Therapy; Hirudins; Male; Partial Thromboplastin Time; Peptide Fragments; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Count; Prothrombin; Prothrombin Time; Recombinant Proteins; Recurrence; Safety; Thrombin; Thrombolytic Therapy; Tissue Plasminogen Activator | 1997 |
Interspecies comparison of the antiplatelet, antithrombotic, and hemorrhagic effects of SR 121566A, a novel nonpeptide GP IIb/IIIa antagonist.
Topics: Adenosine Diphosphate; Animals; Arteriovenous Shunt, Surgical; Benzylamines; Dogs; Fibrinolytic Agents; Guinea Pigs; Hemorrhage; Humans; In Vitro Techniques; Male; Mice; Papio; Piperidines; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Rabbits; Rats; Species Specificity; Thiazoles | 1999 |
In vitro and in vivo effects of desmopressin on platelet function.
Topics: Adenosine Diphosphate; Antigens, CD; Bleeding Time; Blood Platelets; Collagen; Deamino Arginine Vasopressin; Hemorrhage; Humans; Platelet Activation; Platelet Aggregation | 1999 |
Use of the PFA-100 apparatus to assess platelet function in patients undergoing PTCA during and after infusion of c7E3 Fab in the presence of other antiplatelet agents.
Topics: Abciximab; Adenosine Diphosphate; Angioplasty, Balloon, Coronary; Antibodies, Monoclonal; Anticoagulants; Blood Cell Count; Collagen; Epinephrine; Equipment Design; Female; Hemoglobins; Hemorrhage; Heparin; Humans; Immunoglobulin Fab Fragments; Male; Microcomputers; Middle Aged; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Function Tests; Pulmonary Embolism | 2000 |
Identification of the platelet ADP receptor targeted by antithrombotic drugs.
Topics: Adenosine Diphosphate; Amino Acid Sequence; Animals; Blood Platelets; Brain; CHO Cells; Chromosomes, Human, Pair 3; Cloning, Molecular; Cricetinae; Cyclic AMP; DNA, Complementary; Female; Fibrinolytic Agents; Frameshift Mutation; G Protein-Coupled Inwardly-Rectifying Potassium Channels; GTP-Binding Proteins; Hemorrhage; Humans; Male; Membrane Proteins; Molecular Sequence Data; Oocytes; Platelet Aggregation; Potassium; Potassium Channels; Potassium Channels, Inwardly Rectifying; Rats; Receptors, Purinergic P2; Receptors, Purinergic P2Y12; Tissue Distribution; Xenopus | 2001 |
Purification and characterization of a phospholipase A2 isoenzyme isolated from Lachesis muta snake venom.
Topics: Adenosine Diphosphate; Amino Acid Sequence; Animals; Blood Platelets; Collagen; Edema; Hemolysis; Hemorrhage; Isoenzymes; Molecular Sequence Data; Phospholipases A; Phospholipases A2; Platelet Aggregation Inhibitors; Sequence Homology, Amino Acid; Viper Venoms; Viperidae | 2002 |
The regulation of platelet-dense granules by Rab27a in the ashen mouse, a model of Hermansky-Pudlak and Griscelli syndromes, is granule-specific and dependent on genetic background.
Topics: Adenosine Diphosphate; Adenosine Triphosphate; Animals; Blood Platelets; Cytoplasmic Granules; Disease Models, Animal; Genetic Predisposition to Disease; Hemorrhage; Hermanski-Pudlak Syndrome; Mice; Mice, Mutant Strains; Platelet Storage Pool Deficiency; rab GTP-Binding Proteins; rab27 GTP-Binding Proteins; Serotonin | 2002 |
A potent new inhibitor of platelet aggregation and experimental thrombosis, anagrelide (BL-4162A).
Topics: Adenosine Diphosphate; Animals; Carotid Arteries; Collagen; Dogs; Electricity; Fibrinolytic Agents; Haplorhini; Hemorrhage; Humans; Imidazoles; Lasers; Macaca mulatta; Platelet Aggregation; Quinazolines; Rabbits; Rats; Thrombosis | 1979 |
Pulmonary reperfusion syndrome.
Topics: Adenosine Diphosphate; Adenosine Triphosphate; Animals; Constriction; DNA; Dogs; Glycogen; Hemorrhage; Ischemia; Lactates; Lung; Lung Diseases; Pulmonary Artery; Pulmonary Edema; Time Factors | 1979 |
Bleeding time in uremia: a useful test to assess clinical bleeding.
Topics: Adenosine Diphosphate; Aged; Bleeding Time; Blood Urea Nitrogen; Creatinine; Epinephrine; Hemorrhage; Humans; Middle Aged; Platelet Aggregation; Platelet Function Tests; Uremia | 1979 |
Conjunctival bleeding in Osler's disease with associated platelet dysfunction. A case report.
Topics: Adenosine Diphosphate; Aged; Blood Platelet Disorders; Clot Retraction; Collagen; Conjunctiva; Epinephrine; Eye Diseases; Female; Hemorrhage; Humans; Platelet Aggregation; Telangiectasia, Hereditary Hemorrhagic | 1978 |
[Energy potential of the cerebral cortex in the pre-agonal and post-resuscitation period after acute blood loss].
Topics: Acute Disease; Adenine Nucleotides; Adenosine Diphosphate; Adenosine Monophosphate; Adenosine Triphosphate; Animals; Brain Chemistry; Dogs; Female; Hemorrhage; Male; Resuscitation | 1977 |
Acquired decrease in platelet secretory ADP associated with increased postoperative bleeding in post-cardiopulmonary bypass patients and in patients with severe valvular heart disease.
Topics: Adenosine Diphosphate; Adenosine Triphosphate; Blood Platelets; Cardiopulmonary Bypass; Heart Valve Diseases; Hemorrhage; Humans; Time Factors | 1978 |
Hemorrhagic tendency in beta-thalassemia major.
Topics: Adenosine Diphosphate; Adolescent; Adult; Blood Coagulation Tests; Child; Child, Preschool; Collagen; Epinephrine; Female; Hemorrhage; Humans; Male; Platelet Aggregation; Ristocetin; Thalassemia | 1978 |
The hemostatic mechanism after open-heart surgery. II. Frequency of abnormal platelet functions during and after extracorporeal circulation.
Topics: Adenosine Diphosphate; Blood Cell Count; Blood Platelet Disorders; Blood Platelets; Blood Proteins; Cardiac Surgical Procedures; Collagen; Epinephrine; Extracorporeal Circulation; Fibrin; Fibrinogen; Hemorrhage; Humans; Platelet Adhesiveness; Platelet Aggregation; Platelet Factor 3; Postoperative Complications; Prospective Studies; Protamines; Time Factors | 1975 |
Effects of somatostatin on hemostasis in baboons.
Topics: Adenosine Diphosphate; Animals; Blood Cell Count; Blood Coagulation; Blood Coagulation Tests; Blood Platelets; Collagen; Epinephrine; Fibrinogen; Hemorrhage; Hemorrhagic Disorders; Hemosiderin; Hemostasis; Infusions, Parenteral; Lung; Lung Diseases; Male; Papio; Platelet Aggregation; Somatostatin; Thrombocytopenia | 1975 |
Identification of a new congenital defect of platelet function characterized by severe impairment of platelet responses to adenosine diphosphate.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Adenosine Diphosphate; Blood Platelets; Calcium; Clot Retraction; Collagen; Cyclic AMP; Epinephrine; Fibrinogen; Hemorrhage; Humans; Indomethacin; Kinetics; Male; Middle Aged; Platelet Activating Factor; Platelet Aggregation; Platelet Membrane Glycoproteins; Prostaglandin Endoperoxides, Synthetic; Reference Values; Thrombin; Vasoconstrictor Agents; von Willebrand Factor | 1992 |
A defect of platelet aggregation associated with an abnormal distribution of glycoprotein IIb-IIIa complexes within the platelet: the cause of a lifelong bleeding disorder.
Topics: Adenosine Diphosphate; Adult; Antibodies, Monoclonal; Blood Platelets; Electrophoresis, Gel, Two-Dimensional; Electrophoresis, Polyacrylamide Gel; Epinephrine; Fibrinogen; Hemorrhage; Humans; In Vitro Techniques; Male; Microscopy, Electron; Platelet Aggregation; Platelet Membrane Glycoproteins | 1992 |
Hemostatic studies in racing standardbred horses with exercise-induced pulmonary hemorrhage. Hemostatic parameters at rest and after moderate exercise.
Topics: Adenosine Diphosphate; Animals; Antithrombin III; Collagen; Factor VIII; Fibrin; Fibrin Fibrinogen Degradation Products; Fibrinogen; Hematocrit; Hemorrhage; Hemostasis; Horse Diseases; Horses; Lung Diseases; Partial Thromboplastin Time; Physical Exertion; Platelet Activating Factor; Platelet Aggregation; Platelet Count; Prothrombin Time; Thrombin Time; von Willebrand Factor | 1991 |
Direct detection of activated platelets and platelet-derived microparticles in humans.
Topics: Adenosine Diphosphate; Antibodies, Monoclonal; Blood Platelets; Cardiopulmonary Bypass; Fibrinogen; Flow Cytometry; Hemorrhage; Humans; In Vitro Techniques; Platelet Activation; Platelet Membrane Glycoproteins | 1990 |
Correlation between template bleeding times and spontaneous bleeding during treatment of acute myocardial infarction with recombinant tissue-type plasminogen activator.
Topics: Adenosine Diphosphate; Aspirin; Bleeding Time; Emergencies; Fibrin Fibrinogen Degradation Products; Hematocrit; Hemorrhage; Hemostasis; Humans; Myocardial Infarction; Platelet Aggregation; Recombinant Proteins; Time Factors; Tissue Plasminogen Activator | 1989 |
Whole blood platelet aggregation in dogs with liver disease.
Topics: Adenosine Diphosphate; Animals; Arachidonic Acids; Collagen; Dog Diseases; Dogs; Female; Hemorrhage; Liver Diseases; Male; Platelet Aggregation | 1989 |
A plasma inhibitor of platelet aggregation in patients with Lassa fever.
Topics: Adenosine Diphosphate; Hemorrhage; Humans; Lassa Fever; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Count | 1989 |
Whole blood platelet aggregation in uremic dogs.
Topics: Adenosine Diphosphate; Animals; Arachidonic Acids; Collagen; Dog Diseases; Dogs; Female; Hemorrhage; Male; Platelet Aggregation; Platelet Count; Urea; Uremia | 1989 |
Evidence for the dependence of arterial haemostasis on ADP.
Topics: Adenine Nucleotides; Adenosine Diphosphate; Animals; Apyrase; Hemorrhage; Hemostasis; Male; Mesenteric Arteries; Mesenteric Veins; Mice; Phosphoric Monoester Hydrolases; Rats; Rats, Inbred Strains; Receptors, Purinergic; Reference Values | 1988 |
An unclassified platelet function disorder associated with bleeding tendency.
Topics: Adenosine Diphosphate; Adenosine Triphosphate; beta-Thromboglobulin; Bleeding Time; Blood Platelet Disorders; Blood Platelets; Child; Clot Retraction; Hemorrhage; Humans; Male; Platelet Adhesiveness; Platelet Factor 4 | 1987 |
Platelets and antithrombin III in uraemia: the acute effect of haemodialysis.
Topics: Adenosine Diphosphate; Adult; Aged; Antithrombin III; beta-Thromboglobulin; Female; Hematocrit; Hemorrhage; Humans; Male; Middle Aged; Platelet Aggregation; Platelet Count; Renal Dialysis; Uremia | 1985 |
Impact of aspirin and chlorthalidone on the pharmacodynamics of oral anticoagulant drugs in man.
Topics: Adenosine Diphosphate; Adenosine Triphosphate; Adult; Anticoagulants; Aspirin; Blood Coagulation Tests; Blood Platelets; Chlorthalidone; Collagen; Dicumarol; Epinephrine; Hematocrit; Hemorrhage; Humans; Male; Metabolism; Platelet Adhesiveness; Prothrombin Time; Sodium; Warfarin | 1971 |
Possible thrombosthenin defect in Glanzmann's thrombasthenia.
Topics: Adenosine Diphosphate; Adenosine Triphosphate; Animals; Antibodies; Blood Coagulation Tests; Blood Platelet Disorders; Blood Platelets; Clot Retraction; Hemorrhage; Humans; Immune Sera; Immunodiffusion; Microscopy, Electron; Peroxidases; Platelet Adhesiveness; Purpura, Thrombocytopenic; Rabbits; Staining and Labeling; Surface Properties | 1972 |
Impaired platelet function in glucose-6-phosphatase deficiency.
Topics: Adenosine Diphosphate; Blood Platelets; Child; Child, Preschool; Female; Fructose-Bisphosphate Aldolase; Glucosidases; Glucosyltransferases; Glycogen Storage Disease; Glycogen Storage Disease Type I; Hemorrhage; Humans; In Vitro Techniques; Infant; Liver Diseases; Male; Parenteral Nutrition; Platelet Adhesiveness; Pyruvate Kinase | 1974 |
Blood and neoplastic diseases. Haemostasis, haemorrhage, and thrombosis.
Topics: Adenosine Diphosphate; Animals; Aspirin; Blood Coagulation; Blood Coagulation Factors; Blood Platelets; Blood Vessels; Dextrans; Disseminated Intravascular Coagulation; Fibrinolysin; Fibrinolysis; Hemorrhage; Hemostasis; Humans; Platelet Adhesiveness; Snakes; Thrombosis; Venoms | 1974 |
The hemostatic defect produced by carbenicillin.
Topics: Adenosine Diphosphate; Bacterial Infections; Blood Cell Count; Blood Coagulation; Blood Coagulation Disorders; Blood Coagulation Tests; Blood Platelets; Carbenicillin; Clot Retraction; Collagen; Epinephrine; Hemorrhage; Humans; Infusions, Parenteral; Male; Platelet Adhesiveness; Prothrombin Time; Time Factors | 1974 |
[Letter: Study of effects of 4 replacement solutions with a fluid gelatin base on platelet aggregation].
Topics: Adenosine Diphosphate; Gelatin; Hemorrhage; Humans; Plasma Substitutes; Platelet Adhesiveness; Platelet Aggregation | 1974 |
[Clinical forms and therapy of thrombopenic syndromes].
Topics: Adenosine Diphosphate; Blood Platelet Disorders; Child; Hemorrhage; Humans; Leukemia, Myeloid; Purpura, Thrombocytopenic; Thrombelastography; von Willebrand Diseases | 1972 |
Hereditary giant platelet syndrome: a disorder of a new aspect of platelet function.
Topics: Adenosine Diphosphate; Adolescent; Blood Platelet Disorders; Child; Collagen; Female; Fibrinogen; Hemorrhage; Humans; Plasma; Platelet Adhesiveness; Prothrombin; Purpura, Thrombocytopenic; Ristocetin; Syndrome; Thrombin; von Willebrand Diseases | 1973 |
Thrombopathy. Identification and distribution.
Topics: Adenosine Diphosphate; Aspirin; Blood Coagulation Factors; Blood Coagulation Tests; Blood Platelet Disorders; Blood Platelets; Diagnosis, Differential; Epinephrine; Factor VIII; Female; Hemorrhage; Hemostasis; Humans; Platelet Adhesiveness; Prothrombin Time; Retrospective Studies; von Willebrand Diseases | 1974 |
A case of thrombasthenia with a study of platelet aggregation by hydrogen peroxide (H 2 O 2 ).
Topics: Adenosine; Adenosine Diphosphate; Adolescent; Adult; Blood Coagulation Tests; Blood Platelet Disorders; Blood Platelets; Child; Edetic Acid; Ethylmaleimide; Female; Glutathione; Hemorrhage; Humans; Hydrogen Peroxide; In Vitro Techniques; Purpura, Thrombocytopenic | 1972 |
Bleeding tendency with platelet dysfunction and albinism. A case report.
Topics: Adenosine Diphosphate; Adenosine Triphosphate; Albinism; Blood Coagulation Factors; Blood Coagulation Tests; Blood Platelet Disorders; Blood Platelets; Child; Clot Retraction; Collagen; Epinephrine; Hemorrhage; Humans; Inosine Nucleotides; Male; Pedigree; Platelet Adhesiveness; Prothrombin Time | 1972 |
Clinical and biochemical characteristics of a primary platelet disorder.
Topics: Adenine Nucleotides; Adenosine Diphosphate; Ascorbic Acid; Aspirin; Blood Coagulation Factors; Blood Coagulation Tests; Blood Platelet Disorders; Blood Platelets; Cell Membrane; Collagen; Epinephrine; Glass; Hemorrhage; Humans; In Vitro Techniques; Kaolin; Platelet Adhesiveness; Temperature; Thrombin | 1972 |
Glanzmann's thrombasthenia and reduced glutathione.
Topics: Adenosine Diphosphate; Blood Platelet Disorders; Blood Platelets; Glutathione; Hemorrhage; Humans; Oxidation-Reduction; Peroxidases; Platelet Adhesiveness; Purpura, Thrombocytopenic; Syndrome | 1972 |
Abnormalities of platelet function in patients with polycythemia vera.
Topics: Adenosine Diphosphate; Adolescent; Adult; Aged; Blood Cell Count; Blood Coagulation Tests; Blood Platelet Disorders; Child; Collagen; Epinephrine; Female; Hematocrit; Hemorrhage; Humans; Male; Middle Aged; Platelet Adhesiveness; Polycythemia Vera; Thrombin; Thrombosis | 1973 |
Preoperative and postoperative platelet function in cyanotic congenital heart disease.
Topics: Adenosine Diphosphate; Adolescent; Blood Cell Count; Blood Platelets; Carbon Radioisotopes; Child; Child, Preschool; Cyanosis; Epinephrine; Female; Heart Defects, Congenital; Hemorrhage; Humans; Infant; Male; Platelet Adhesiveness; Polycythemia; Postoperative Complications; Serotonin; Time Factors | 1974 |
Cellular alterations with shock and ischemia.
Topics: Adenosine Diphosphate; Animals; Cations, Monovalent; Cattle; Citric Acid Cycle; Electron Transport; Fatty Acids, Nonesterified; Glycolysis; Hemorrhage; Hydroxybutyrates; Ischemia; Ketoglutaric Acids; Liver; Microscopy, Electron; Mitochondria; Mitochondria, Liver; Oxygen; Rats; Respiration; Serum Albumin, Bovine; Shock; Sodium; Succinates | 1974 |
Haemostatic defects in polycythaemia vera.
Topics: Adenosine Diphosphate; Adult; Aged; Antithrombins; Blood Cell Count; Blood Coagulation; Blood Coagulation Factors; Blood Coagulation Tests; Blood Platelets; Clot Retraction; Collagen; Disseminated Intravascular Coagulation; Epinephrine; Female; Fibrin; Fibrinogen; Fibrinolysis; Hemorrhage; Humans; Male; Middle Aged; Plasminogen; Platelet Adhesiveness; Polycythemia Vera; Prothrombin Time; Thrombin; Thrombophlebitis | 1974 |
Release reaction in washed platelet suspensions induced by kaolin and other particles.
Topics: Adenine Nucleotides; Adenosine Diphosphate; Aspirin; Blood Platelet Disorders; Blood Platelets; Calcium; Centrifugation; Edetic Acid; Hemorrhage; Heparin; Humans; Kaolin; Latex; Microspheres; Platelet Adhesiveness; Purpura, Thrombocytopenic; Spectrophotometry; Thrombin; von Willebrand Diseases | 1971 |
Disorders of platelet function.
Topics: Adenosine Diphosphate; Blood Platelet Disorders; Hemorrhage; Humans; Platelet Adhesiveness; Uremia | 1972 |
Dozing and bruising due to abnormal platelet function (thrombocytopathia). A family study of the syndrome.
Topics: Adenosine Diphosphate; Adolescent; Adult; Blood Coagulation Tests; Blood Platelet Disorders; Blood Platelets; Child; Child, Preschool; Collagen; Epinephrine; Female; Genes, Dominant; Hematoma; Hemorrhage; Humans; Male; Menorrhagia; Middle Aged; Mucous Membrane; Pedigree; Postoperative Complications; Prednisone; Syndrome | 1972 |
Classification of thrombocytosis based on platelet function tests: correlation with hemorrhagic and thrombotic complications.
Topics: Adenosine Diphosphate; Adult; Aged; Blood Cell Count; Blood Coagulation Factors; Blood Coagulation Tests; Blood Platelets; Collagen; Epinephrine; Female; Hemorrhage; Humans; Lipoproteins; Male; Middle Aged; Myeloproliferative Disorders; Platelet Adhesiveness; Prothrombin Time; Splenectomy; Thrombocytosis; Thrombosis | 1972 |
The phospholipid and fatty acid composition of platelets in patients with primary defects of platelet function.
Topics: Adenosine Diphosphate; Adult; Blood Coagulation; Blood Platelet Disorders; Blood Platelets; Child; Chromatography, Gas; Collagen; Epinephrine; Fatty Acids; Fatty Acids, Essential; Female; Hemorrhage; Humans; Lysophosphatidylcholines; Male; Middle Aged; Phosphatidylcholines; Phosphatidylethanolamines; Phospholipids; Purpura, Thrombocytopenic; Sphingomyelins | 1972 |
Changes in the oxyhemoglobin dissociation curve and peripheral blood after acute red cell mass depletion and subsequent red cell mass restoration in baboons.
Topics: Adaptation, Physiological; Adenosine Diphosphate; Adenosine Triphosphate; Animals; Blood Preservation; Blood Transfusion, Autologous; Blood Volume; Body Weight; Creatine; Erythrocytes; Glutathione; Hematocrit; Hemoglobins; Hemorrhage; Heparin; Hydrogen-Ion Concentration; Lactates; Oxygen; Oxygen Consumption; Papio; Phosphorus; Pyruvates; Sodium Chloride | 1971 |
Platelet adhesiveness and aggregability after acute haemorrhage in the dog.
Topics: Adenosine Diphosphate; Animals; Blood Cell Count; Blood Platelets; Bloodletting; Cell Aggregation; Dogs; Female; Hematocrit; Hemorrhage; Male; Platelet Adhesiveness; Time Factors | 1971 |
Recent data on thrombasthenia.
Topics: Adenosine Diphosphate; Animals; Blood Platelet Disorders; Blood Platelets; Collagen; Epinephrine; Hemagglutination; Hemorrhage; Humans; Immune Sera; Kaolin; Neuraminic Acids; Purpura, Thrombocytopenic; Rabbits | 1971 |
Platelet behaviour in dogs during and after moderate and severe haemorrhage.
Topics: Adenosine Diphosphate; Anesthesia, Inhalation; Anesthesia, Intravenous; Animals; Blood Cell Count; Blood Platelets; Blood Transfusion, Autologous; Blood Volume; Dogs; Hematocrit; Hemorrhage; Platelet Adhesiveness; Shock, Hemorrhagic | 1969 |
The effect of hemorrhage on platelets.
Topics: Adenosine Diphosphate; Animals; Blood Cell Count; Blood Platelets; Cell Aggregation; Dogs; Hemorrhage; Platelet Adhesiveness; Shock, Hemorrhagic; Thrombocytosis | 1969 |
[Platelet factor 3 release in Glanzmann's disease].
Topics: Adenosine Diphosphate; Blood Coagulation; Blood Platelet Disorders; Blood Platelets; Hemorrhage; Humans; Purpura, Thrombocytopenic | 1969 |